Ionis Pharmaceuticals, Inc.
Compounds and Methods for the Modulation of Proteins
Last updated:
Abstract:
In certain embodiments, the present disclosure provides compounds and methods of increasing the amount or activity of a target protein in a cell. In certain embodiments, the compounds comprise a translation suppression element inhibitor. In certain embodiments, the translation suppression element inhibitor is a uORF inhibitor. In certain embodiments, the uORF inhibitor is an antisense compound.
Status:
Application
Type:
Utility
Filling date:
15 Sep 2020
Issue date:
2 Sep 2021